Business Wire

WIBA

Share
The Sixth Annual WIBA Awards 2024 Honors the Most Impactful Personalities on Social Media at the Ceremony During Cannes Film Festival

The sixth annual WIBA Awards for social media personalities on a mission to change the world will take place on May 24th, 2024, at the iconic Hotel Martinez during Cannes Film Festival. The event gathers hundreds of top global content creators responsible for the year’s most viral moments. The evening features a cocktail reception, a Gala Dinner, and the Awards ceremony with a special performance by Sonique.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240426909677/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

WIBA Awards 2023 Winners (Photo: Business Wire)

WIBA Awards are overseen by the World Influencers Association (WIBA) based in Monaco. It is the first and the only international award honoring the work of social media personalities across multiple categories ranging from Best Beauty Influencer to Best Pet Influencer.

In 2023, Forbes magazine described the event in inspired terms. “The annual World Influencers Awards gathers who-is-who of viral moments as well as pioneers of digital longevity for the most high-powered networking event on Côte d’Azur.” Given the celebrity wattage of so much virtual talent rarely present in the same physical space, the WIBA Ceremony is an exciting newsworthy opportunity to check the world’s social media pulse.

WIBA Awards recipients entertain and educate massive audiences on an unprecedented scale. Previous title holders include Maye Musk, Khaby Lame, Richard Orlinski, Nusret Gökçe, Ellen Von Unwerth, Gianluca Vacchi, Kat Graham, Kelly Rutherford, Coco Rocha, among other Internet stars. The typical instant reach of a WIBA Awards ballroom is over 200 million impressions.

Mariia Grazhina Chaplin, CEO of WIBA: “I am proud to announce the sixth edition of the WIBA Awards. As this distinctive event coincides with the Cannes Film Festival, the title holders, influencers not only entertain their audiences with memorable images, but also inform them about the latest developments in cinema from the industry’s most significant platform. As we honor the Crème de la Crème of Right Now, we are also nurturing the opinion leaders and trendsetters of Tomorrow. Later in 2024, we plan to bring WIBA events to the United States and the Middle East to further our educational mission. We want to channel influencers' potential into a global power to act for the better, striving for universal peace and equal opportunities for all.”

www.wiba.global

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240426909677/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 09:00:00 CET | Press release

Acquisition will accelerate Ramudden’s ambitious growth plan across North America and Europe supported by strong infrastructure spending tailwinds I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that unde

RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta7.1.2026 09:00:00 CET | Press release

RoslinCT, a global contract development and manufacturing organization (CDMO) specializing in advanced cell therapies, and BOOST Pharma, a clinical-stage biotechnology company developing first-in-class cell therapies for rare paediatric skeletal diseases, today announced a strategic manufacturing partnership to support the development of BOOST Pharma’s cell therapy, BT-101, for the treatment of infants with Osteogenesis Imperfecta (OI), also known as brittle bone disease. Under the service agreement, BOOST Pharma has transferred its manufacturing process to RoslinCT’s state-of-the-art facilities in Edinburgh, Scotland. The partnership will progress toward GMP manufacturing of starting materials and clinical drug product, supporting Phase III clinical development of BT-101. The therapy is an allogeneic mesenchymal stem cell (MSC) product designed to address the underlying cause of OI at the earliest stages of life. BOOST Pharma was founded on pioneering science originating from Karolins

Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe7.1.2026 08:30:00 CET | Press release

Exclusive agreement covers 13 Central and Eastern European markets Collaboration will help expand access to VANFLYTA for patients with newly diagnosed FLT3-ITD positive AML Daiichi Sankyo (TSE: 4568) and GENESIS Pharma have entered into an exclusive license and supply agreement for the distribution and commercialization of VANFLYTA® (quizartinib) in 13 markets across Central and Eastern Europe for the treatment of adult patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML). Under the terms of the agreement, Daiichi Sankyo will be responsible for the manufacturing and supply of VANFLYTA while GENESIS Pharma will lead medical affairs, market access and commercialization efforts in Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Romania, Slovakia and Slovenia. Financial terms of the agreement are not being disclosed. VANFLYTA was approved in the EU in November 2023 for the treatment of adult patients with newly diagnose

Thales Powers CES*-Winning Post-Quantum Chip From Samsung Electronics7.1.2026 08:15:00 CET | Press release

*Consumer Electronics Show, January 6-9, Las Vegas, NV, USA Thales’ secure operating system (OS) supports Samsung's security chip, winner of the CES 2026 ‘Best Cybersecurity Innovation’ Award. The chip is the first embedded Secure Element (eSE) to integrate post-quantum cryptography (PQC), protecting devices against tomorrow’s quantum-enabled cyber threats. Thales’ quantum-resistant software and OS enable unmatched performance, energy efficiency and long-term data protection. Quantum computers, with their unprecedented processing power, will ultimately challenge today’s encryption standards. This is why Thales welcomes the CES 2026 recognition awarded to the new post-quantum–ready security chip from Samsung Electronics' System LSI Business, which embeds Thales’ secure operating system and quantum-resistant cryptographic libraries. This breakthrough represents a major step forward in protecting connected devices against both current cyberattacks and tomorrow’s quantum-era threats. This

Heath Hoglund Joins Sisvel as Chief IP Officer7.1.2026 07:00:00 CET | Press release

Sisvel is pleased to announce the appointment of Heath Hoglund as the company’s first-ever Chief Intellectual Property Officer. In this role he will be fully responsible for the firm’s patent pools on a global basis. One of the world’s top IP dealmakers, Hoglund joins Sisvel having taken the decision to leave Via Licensing, where he was an outstanding President for four years. Prior to that, he had been Vice-President of IP and Standards at Dolby, overseeing the company’s patent portfolio, its patent licensing programmes, and leading on the formation and design of numerous patent pools and standards initiatives. The appointment creates a new Licensing and Programme Management leadership structure at Sisvel. This will strengthen collaboration between the functions, increasing Sisvel’s considerable growth potential. Licensing and Programme Management heads, Nick Webb and David Muus, will continue to lead their respective areas, retaining all current responsibilities. Heath Hoglund’s trac

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye